Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06580782 · ClinicalTrials.gov registry record · Phase 4
Calcium Carbonate to Augment Labor Contractions
A Phase 4 study of Labor Dystocia and Labor Induction, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06580782: Recruiting Phase 4 study of Labor Dystocia and Labor Induction, sponsored by Weill Medical College of Cornell University.
NCT06580782 is a Phase 4 study of Labor Dystocia and Labor Induction that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 60 participants, below the 213-participant average among 3 other Labor Dystocia trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06580782, a Phase 4 study of Labor Dystocia and Labor Induction, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.
Primary Outcome
RedCAP is used to track the consent rates to determine the feasibility of a larger randomized controlled trial.
Conditions Studied
Interventions
- DRUG Calcium Carbonate 500 MG
- DRUG Standard Dose Synthetic Pitocin
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-11-18 |
| Est. Completion | 2025-12 |
| Phase | Phase 4 |
What NCT06580782 shows while recruiting
NCT06580782 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 213-participant average among 3 other Labor Dystocia trials with a reported enrollment target (72% lower).
The record links to 3 conditions, with Labor Dystocia appearing as the primary indexed condition, and to 2 interventions - of which Calcium Carbonate 500 MG is the first listed.
NCT06580782 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06580782 about?
NCT06580782 is a clinical study titled "Calcium Carbonate to Augment Labor Contractions". The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.
What is the current status of trial NCT06580782?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2024-11-18. Estimated completion is 2025-12.
What conditions does trial NCT06580782 study?
This clinical trial studies the following conditions: Labor Dystocia, Labor Induction, Labor Augmentation.
What interventions are being tested in trial NCT06580782?
The interventions under investigation include: Calcium Carbonate 500 MG (DRUG), Standard Dose Synthetic Pitocin (DRUG).
Who is sponsoring clinical trial NCT06580782?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06580782 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Labor Dystocia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI